Cutting Edge: Granulocyte-Macrophage Colony-Stimulating Factor Is the Major CD8+ T Cell-Derived Licensing Factor for Dendritic Cell Activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cutting Edge: Granulocyte-Macrophage Colony-Stimulating Factor Is the Major CD8+ T Cell-Derived Licensing Factor for Dendritic Cell Activation

Published:2010-03-31 Issue:9 Volume:184 Page:4625-4629
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Min Lin,Mohammad Isa Siti Aminah Bte,Shuai Wang,Piang Cher Boon,Nih Fam Wee,Kotaka Masayo,Ruedl Christiane

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference20 articles.

1. Dendritic cells and the control of immunity

2. Pathogen recognition in the innate immune response

3. Duration, combination and timing: the signal integration model of dendritic cell activation

4. Dendritic cells in a mature age

5. CD8+ T Cells Mediate CD40-independent Maturation of Dendritic Cells In Vivo

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells;Journal for ImmunoTherapy of Cancer;2024-03

2. Short-term inhalation of sargramostim with concomitant high-dose steroids does not hasten recovery in moderate COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial;Infectious Diseases;2023-09-20

3. Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression;eLife;2023-08-07

4. Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity;Science Translational Medicine;2023-01-04

5. New insights on granulocyte-macrophage colony-stimulating factor (GM-CSF) as potential therapeutic target for immune-mediated neurological disorders;Translational Neuroimmunology, Volume 7;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3